$ORGO

$0.90 -$0.03 (3.53%) Close

$ORGO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 128.7M shares outstanding

Who owns ORGO?

By type of holder

Institutions 51.6% Insiders 0.4% Everyone else 48.0%

Concentration Top 10 holders own 91.0%

Alan A. Ades 17.4% · Albert Erani 13.9%

Institutional ownership

51.6%

+3.6 pts vs last qtr

Institutional holders

134

+13 vs last qtr

Net shares bought

+4.7M

by institutions in Q2 2026

New / sold out

31 / 18

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +2.3M
Aqr Capital Management LLC +2.1M

Biggest sellers in Q2 2026

First Light Asset Management, LLC SOLD OUT −3.5M
Los Angeles Capital Management LLC −427.4K

Who is planning to sell?

Notices of proposed sale, last 12 months

$2.64M

3 notices from 1 person

Shares covered

500.0K

0.39% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Glenn Nussdorf Director $2.64M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2018–FY2025

+87.9%

+9.43% a year

Each share's claim on the business

−46.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$25.5M vs $47M

over 8 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years65% 3–5 years23% 1–3 years3% Under 1 year9%

Quarterly turnover

13.8%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting ORGO on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MS Morgan Stanley	11.7M	9.11%	+104.8K (+0.9%)	≤2021	0.0%
Shares held by quarter Peak holding12.1M (Q1'25) Change over 8 quarters−248.1K Share of the company9.110% Morgan Stanley's full portfolio →
SC Soleus Capital Management, L.P.	10.1M	7.88%	+55.0K (+0.5%)	2021	0.9%
Shares held by quarter Peak holding12.5M (Q4'24) Change over 8 quarters−1.7M Share of the company7.880% Soleus Capital Management, L.P.'s full portfolio →

Morgan Stanley

11.7M

% of company

9.11%

Change vs last qtr

+104.8K (+0.9%)

Held since

≤2021

Soleus Capital Management, L.P.

10.1M

% of company

7.88%

Change vs last qtr

+55.0K (+0.5%)

Held since

2021

28 more super investors behind a free account

See every manager holding Organogenesis Holdings Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ORGO on Form N-PORT; together they hold 12.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$4.84M	2.0M	1.55%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$4.38M	1.8M	1.40%	0.01%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$4.84M

% of company

1.55%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$4.38M

% of company

1.40%

% of the fund

0.01%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Organogenesis Holdings Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
AA Alan A. Ades 5%+ holder 13D · 17.6%	22.3M	17.35%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company17.350% Disclosed stake13D · 17.6% View the 13D/G filing →
AE Albert Erani 5%+ holder 13D · 14.1%	17.9M	13.93%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company13.930% Disclosed stake13D · 14.1% View the 13D/G filing →

Alan A. Ades

5%+ holder13D · 17.6%

22.3M

% of company

17.35%

Change vs last qtr

—

Held since

—

Albert Erani

5%+ holder13D · 14.1%

17.9M

% of company

13.93%

Change vs last qtr

—

Held since

—

15 more holders behind a free account

See every insider and 5%+ holder of Organogenesis Holdings Inc..

Comments